Page last updated: 2024-09-03

y 27632 and Peripheral Nerve Diseases

y 27632 has been researched along with Peripheral Nerve Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carrion-Jones, M; Dunham, M; James, SE; Lu, Q; Murashov, A	1

Other Studies

1 other study(ies) available for y 27632 and Peripheral Nerve Diseases

Article	Year
Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin. Neurotoxicology, 2010, Volume: 31, Issue:2 Topics: Amides; Animals; Antineoplastic Agents; Cisplatin; Disease Models, Animal; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Nerve Regeneration; Neural Conduction; Peripheral Nervous System Diseases; Pyridines; rho-Associated Kinases; Sural Nerve; Touch Perception	2010

Article

Year

Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin.

Neurotoxicology, 2010, Volume: 31, Issue:2

Topics: Amides; Animals; Antineoplastic Agents; Cisplatin; Disease Models, Animal; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Nerve Regeneration; Neural Conduction; Peripheral Nervous System Diseases; Pyridines; rho-Associated Kinases; Sural Nerve; Touch Perception

2010